Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib vs Placebo in Knee OA Non-Responsive to Naproxen/Ibuprofen
NCT00638807Phase 4Completed
- Sponsor
- Viatris
- Start
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of celecoxib oral solution in osteoarthritis (OA) (2 arms), sponsored by Viatris. Primary endpoint: Patient's Assessment of Arthritis Pain, according to visual analog scale at Week 6. Started Dec 2003; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00638807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638807.